AAV / Viral Vector Platform CROs
12 published
12 published CROs match AAV / Viral Vector Platform.
Locations in this set include United States, China, Singapore, Multiple, Netherlands, and South Korea.
Capabilities that show up most often in this set: Translational Research, Analytical Method Development & Validation, In Vivo Efficacy Models, Preclinical In Vivo Studies, and Bioanalysis.
Matching companies
Cellentia, Inc.Specialized contract research organization offering custom bioassays, organoid culturing, AAV and MSD assays, PBMC isolation, and patient-derived 3D tumor organoid lines for drug development and translational research.
Charles River LaboratoriesCharles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.
Cyagen BiosciencesCyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.
Cyagen BiosciencesCyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical drug discovery, with specialized platforms including HUGO-GT™ and HUGO-Ab™ for humanized target validation and antibody screening.
Genevoyager (Wuhan) Co., Ltd.Leading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023.
Noble Life SciencesAdvanced preclinical CRO providing comprehensive drug and device development services including bioanalysis, GLP toxicology, pharmacodynamic modeling, and specialized testing for oncology, infectious disease, gene therapy, and synthetic biology programs.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
ProBioProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.
SGVectorSGVector develops and manufactures viral vectors for cell and gene therapies, offering vector design, process development, scale-up, and analytical testing services with a scalable suspension-based platform.
Svar Life Science ABSvar Life Science offers CRO services including bioanalytical testing, biomarker discovery, and GMP QC testing, alongside diagnostic services and cell manufacturing capabilities.
VIRSCIOVirscio is a preclinical CRO offering non-human primate studies, histopathology, and molecular biology services. It supports IND-enabling efficacy, safety, and PK/PD programs in CNS, ophthalmology, and cardiometabolic areas.
uBriGeneuBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.
Markdown mirror: /modalities/aav-vector-platform.md